In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Peter Schwartz
Speaker
Peter Schwartz
Peter Schwartz Peter Schwartz

Italian Institute for Auxology IRCCS, Milan (Italy)

Specialities : Ventricular Arrhythmias and Sudden Cardiac Death (SCD) , Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Peter J. Schwartz, MD is the Director of the Center for Cardiac Arrhythmias of Genetic Origin and of the Cardiovascular Genetics Laboratory at the Istituto Auxologico Italiano, IRCCS, Milan, Italy. From 1995 to 2013 he was Professor and Chairman of Cardiology at the University of Pavia, Italy. His major areas of expertise are the relationship between the autonomic nervous system and life-threatening arrhythmias, the long QT syndrome (LQTS), and risk stratification for sudden death. He received numerous prestigious awards, the latest being the “Fondation Lefoulon-Delalande-Institut de France Grand Prix Scientifique” (2019) which, for cardiovascular medicine, is regarded as the highest award second only to the Nobel Prize. Prof. Schwartz serves the leading cardiology journals as a member of the Editorial Board. Currently, he is the International Associate Editor for Basic Sciences of the European Heart Journal. He has authored more than 1500 publications and his h-index is 124.

12 presentations from this speaker

Wearable ECG Monitoring Technology identifies subjects with a prolonged QT using Deep Learning Algorithms

Event : ESC Congress 2019

  • Session : Artificial Intelligence for Arrhythmias
  • Speaker : PJ Schwartz (Milan,IT), M Smith (Oronoco,US)

Precision medicine in long QT syndrome

Event : EHRA 2018

  • Session : Implication of basic insights for management of channelopathies
  • Speaker : PJ Schwartz (Milan,IT)

LQT3 – the role of Ajmaline challenge and of Flecainide and mexilletine in treatment.

Event : EHRA 2017

  • Session : Medical treatment of channelopathies: effective and safe?
  • Speaker : PJ Schwartz (Milan,IT)

State of the Art: risk stratification for sudden death - What is relevant for clinical practice?

Event : ESC Congress 2017

  • Session : Risk stratification for sudden death in ischaemic and non-ischaemic cardiomyopathy
  • Speaker : PJ Schwartz (Milan,IT)

Vagal stimulation devices.

Event : EHRA 2017

  • Session : Innovative implants for heart failure patients
  • Speaker : PJ Schwartz (Milan,IT)

Asymptomatic patients with long QT syndrome

Event : ESC Congress 2016

  • Session : Management of channelopathies
  • Speaker : PJ Schwartz (Milan,IT)

State of the art in prediction of sudden death

Event : ESC Congress 2016

  • Session : Prediction of sudden death: do we have a crystal ball?
  • Speaker : PJ Schwartz (Milan,IT)

Genetic modifiers for risk stratification and therapy.

Event : EHRA 2015

  • Session : Beyond Mendelian Inheritance in arrhythmias: impact for management.
  • Speaker : PJ Schwartz (Milan,IT)

Role of left cardiac sympathetic denervation and renal denervation.

Event : EHRA 2015

  • Session : Management of catecholaminergic polymorphic ventricular tachycardia
  • Speaker : PJ Schwartz (Milan,IT)

Clinical application of cardiac-neuromodulation: prevention of life-threatening arrhythmias.

Event : ESC Congress 2014

  • Session : Autonomic control of cardiac function: the pivotal role of the heart's 'little brain'
  • Speaker : PJ Schwartz (Milan,IT)

In patients with long QT syndrome.

Event : ESC Congress 2014

  • Session : Inherited arrhythmia syndromes and implantable cardioverter-defibrillator: when to implant?
  • Speaker : PJ Schwartz (Milan,IT)

Vagal nerve stimulation.

Event : ESC Congress 2014

  • Session : Neuromodulation by device therapy in heart failure
  • Speaker : PJ Schwartz (Milan,IT)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are